Ann Beth Stebbins

Ann Beth Stebbins

Partner, Mergers and Acquisitions
Ann Beth Stebbins concentrates primarily on mergers and acquisitions. Ms. Stebbins spent eight years in the firm’s London office and has been involved in a variety of cross-border transactions representing acquirers, targets and financial advisors.

Bio

Ms. Stebbins’ representative transactions include:
  • Amylin Pharmaceuticals, Inc. in its $7 billion acquisition by Bristol-Myers Squibb Company
  • Funds advised by Apax Partners in their acquisitions of:
    • CyberGrants Holdings LLC, a developer of enterprise engagement and grants management software
    • EveryAction, Inc. from Insight Ventures
    • Social Solutions Group, Inc. from Vista Equity Partners
    • Nulo, Inc., a producer and distributor of premium pet food products
    • ECI Software Solutions and the North American business of Exact Group B.V. and its subsequent sale to affiliates of private equity firm Leonard Green & Partners, L.P.
    • a majority stake in Accenture LLP’s Duck Creek insurance software business and the subsequent IPO of the business
    • a controlling interest in FULLBEAUTY Brands, Inc.
    • Quality Distribution, Inc.
    • Advantage Sales & Marketing from J.W. Childs Equity Partners and its subsequent sale to affiliates of Leonard Green & Partners, L.P. and funds advised by CVC Capital Partners Limited
    • Tivit, a leading technology service provider in Brazil
  • Bally Technologies, Inc. in its $5.1 billion acquisition by Scientific Games Corporation, a supplier of instant-win lottery tickets and a manufacturer of lottery terminals
  • Cineworld Group plc in its $3.6 billion acquisition of Regal Entertainment Group
  • Colfax Corporation in the sale of its fluid handling products to CIRCOR International, Inc. and its acquisition of Victor Technologies Group Inc. from Irving Place Capital
  • Crane Co. in connection with corporate governance matters and its abandoned tender offer for CIRCOR International Inc.
  • Gucci Group N.V. in its successful defense against a hostile takeover attempt by LVMH Moët Hennessy Louis Vuitton S.A.; and its independent directors in connection with Pinault-Printemps-Redoute’s acquisition of the publicly held shares of Gucci; and in numerous acquisitions of European luxury goods companies, including Sanofi Beauté (which includes the Yves Saint Laurent clothing and perfume businesses), Balenciaga S.A., Stella McCartney Ltd., Alexander McQueen Ltd. and Bedat S.A.
  • J. C. Penney Company, Inc. in its acquisition of the Liz Claiborne and Monet trademarks from Liz Claiborne, Inc.
  • Pharmaceutical Product Development, Inc. in its $3.9 billion sale to The Carlyle Group and Hellman & Friedman
  • SeaCube Containers, Ltd. in its $1.7 billion acquisition by Ontario Teachers’ Pension Plan
  • the independent members of the board of directors of Time Warner Cable Inc. in its acquisition by Charter Communications
  • WABCO Holdings Inc. in its $7 billion acquisition by ZF Friedrichshafen AG
  • ZeniMax Media Inc. in its $7.5 billion acquisition by Microsoft Corporation

Ms. Stebbins lectures and participates in seminars on topics related to her practice. She was recognized as an Outstanding Women Leader by Georgetown University Law Center and was the 2018 recipient of the John Carroll Award, the highest honor bestowed upon a Georgetown alumnus. She also has been named as one of The American Lawyer’s Dealmakers of the Year, recognized as a Woman Dealmaker of the Year by The M&A Advisor and honored as one of Lawdragon’s 500 Leading Lawyers in America and 500 Leading Dealmakers in America.

Credentials

Education

  • J.D., Georgetown University Law Center, 1994
  • M.B.A., New York University, 1991
  • B.A., Georgetown University, 1986

Admissions

  • New York

Associations

  • Board of Visitors, Georgetown University Law Center
  • Adjunct Professor, Georgetown University Law Center
  • Co-Chair, Public Company Subcommittee of the M&A Committee, American Bar Association

Ann Beth Stebbins

Partner, Mergers and Acquisitions
annbeth.stebbins@skadden.com